Ocumension Therapeutics (HK:1477) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Ocumension Therapeutics has announced a delay in sending out a vital information circular to shareholders, initially planned for September 2, 2024, due to the need for additional time to finalize crucial details. The circular is now expected to be dispatched by September 16, 2024, and will provide comprehensive details about significant company transactions including an acquisition, in-licensing, and share issue, as well as advice from the Independent Board Committee.
For further insights into HK:1477 stock, check out TipRanks’ Stock Analysis page.